Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Morphine treatment restricts response to immunotherapy in oral squamous cell carcinoma

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2024-009962Source: DataRank Database

Morphine treatment restricts response to immunotherapy in oral squamous cell carcinoma is a research paper published in Journal for ImmunoTherapy of Cancer (2024). On theSindex it has a DataRank of 0. It has been cited 18 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access18 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 5.54)OA: goldTopics (59)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Andre A Martel Matos ORCID,Mona Yuan,Megan A. Atherton ORCID,Fendi Obuekwe,Marci L. Nilsen ORCID

Live enrichment

PubMed:39551606 OpenAlex:https://openalex.org/W4404465103

Virginia Kaufman Foundation Pain Research Challenge Award

Grant: N/A

NIH NIDCR

Grant: R01DE033473

National Institutes of Health

Grant: 3P30CA047904-07S1

CANCER CENTER SUPPORT GRANT

National Institutes of Health

Grant: 1S10OD032141-01

An Exploris 240 for Metabolomics

National Institutes of Health

Grant: 1R01DE033473-01A1

Overcoming Immunotherapy Resistance Through Opioid Antagonism in Head and Neck Cancer

NCI NIH HHS

Grant: P30 CA047904

NIH HHS

Grant: S10 OD032141

FWCI

5.54

Citation Percentile

1.0%

Citation Trend

2025

2026

goldLicense: cc-by-nc

journalhttps://jitc.bmj.com/content/12/11/e009962.full.pdf

publisherhttps://jitc.bmj.com/content/12/11/e009962.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1136/jitc-2024-009962

journalhttps://doi.org/10.1136/jitc-2024-009962

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39551606

Fields of Study

Cancer, Stress, Anesthesia, and Immune ResponseNeuropeptides and Animal PhysiologyCancer Immunotherapy and Biomarkers0301 basic medicine0303 health sciences03 medical and health sciencesAnimalsHumansMiceMorphineMouth NeoplasmsImmunotherapySquamous Cell Carcinoma of Head and NeckReceptors, Opioid, muFemaleMaleAnalgesics, OpioidCell Line, Tumor

MeSH Terms

Squamous Cell Carcinoma of Head and NeckAnalgesics, OpioidAnimalsFemaleHumansImmunotherapyMaleMorphineMouth NeoplasmsReceptors, Opioid, muCell Line, TumorMice

Keywords

MedicineCD8Immune systemImmunotherapyImmunosuppressionT cellOpioid receptorCancer researchOpioidPharmacologyImmunologyInternal medicineReceptorMaleMorphineSquamous Cell Carcinoma of Head and NeckReceptors, Opioid, muNeoplasms. Tumors. Oncology. Including cancer and carcinogensBasic Tumor ImmunologyAnalgesics, OpioidMiceCell Line, TumorAnimalsHumansMouth NeoplasmsFemaleRC254-282Head and Neck CancerImmune Checkpoint Inhibitor

Sustainable Development Goals

SDG 0: Good health and well-being